Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/198626
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Torres Martí, Antoni | - |
dc.contributor.author | Soriano Viladomiu, Alex | - |
dc.contributor.author | Rivolo, Simone | - |
dc.contributor.author | Remak, Edit | - |
dc.contributor.author | Peral, Carmen | - |
dc.contributor.author | Kantecki, Michal | - |
dc.contributor.author | Ansari, Wajeeha | - |
dc.contributor.author | Charbonneau, Claudie | - |
dc.contributor.author | Hammond, Jennifer | - |
dc.contributor.author | Grau, Santiago | - |
dc.contributor.author | Wilcox, Mark H. | - |
dc.date.accessioned | 2023-05-29T13:46:38Z | - |
dc.date.available | 2023-05-29T13:46:38Z | - |
dc.date.issued | 2022-03-18 | - |
dc.identifier.issn | 1178-6981 | - |
dc.identifier.uri | http://hdl.handle.net/2445/198626 | - |
dc.description.abstract | Purpose: Complicated skin and soft tissue infections (cSSTI) are associated with high healthcare resource use and costs. The emergency nature of cSSTI hospitalizations requires starting immediate empiric intravenous (IV) antibiotic treatment, making the appropriate choice of initial antibiotic therapy crucial. Patients and methods: The use of ceftaroline fosamil (CFT) as an alternative to other IV antibiotic therapies for the empiric treatment of hospitalized adults with cSSTI (vancomycin, linezolid, daptomycin, cloxacillin, tedizolid) was evaluated through cost consequences analysis. The model structure was a decision tree accounting for four different pathways: patients demonstrating early response (ER) either discharged early (with oral antibiotic) or remaining in hospital to continue the initial therapy; non-responders either remaining on the initial IV therapy or switching to a second-line antibiotic. The model perspective was the Spanish National Health System. Results: CFT resulted in average percentage of patients discharged early (PDE) of 24.6% (CI 19.49-30.2%) with average total cost per patient of 6763 ( 6268- 7219). Vancomycin, linezolid, daptomycin and tedizolid resulted in average PDE of 22% (17.34-27.09%), 26.4% (20.5-32.32%), 28.6% (22.08-35.79%) and 26.5% (20.39-33.25%), respectively, for a total cost per patient of 6,619 ( 5,902- 6,929), 6,394 ( 5,881- 6,904), 6,855 ( 5,800- 7,410) and 7,173 ( 6,608- 7,763), respectively. Key model drivers were ER and antibiotic treatment duration, with hospital costs accounting for over 83% of the total expenditures. Conclusion: Given its clinical and safety profile, CFT is an acceptable choice for cSSTI empiric therapy providing comparable ER and costs to other relevant antibiotic options. | - |
dc.format.extent | 13 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Dove Medical Press | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.2147/CEOR.S329494 | - |
dc.relation.ispartof | Clinicoeconomics and Outcomes Research, 2022, vol. 14, p. 149-161 | - |
dc.relation.uri | https://doi.org/10.2147/CEOR.S329494 | - |
dc.rights | cc-by-nc (c) Torres Martí, Antoni et al., 2022 | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc/4.0/ | - |
dc.source | Articles publicats en revistes (Medicina) | - |
dc.subject.classification | Malalties de la pell | - |
dc.subject.classification | Complicacions (Medicina) | - |
dc.subject.classification | Antibiòtics betalactàmics | - |
dc.subject.classification | Malalts hospitalitzats | - |
dc.subject.classification | Anàlisi econòmica | - |
dc.subject.classification | Espanya | - |
dc.subject.other | Skin diseases | - |
dc.subject.other | Complications (Medicine) | - |
dc.subject.other | Beta lactam antibiotics | - |
dc.subject.other | Hospital patients | - |
dc.subject.other | Economic analysis | - |
dc.subject.other | Spain | - |
dc.title | Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health System | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 731149 | - |
dc.identifier.idgrec | 9301625 | - |
dc.date.updated | 2023-05-29T13:46:39Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 35330907 | - |
Appears in Collections: | Articles publicats en revistes (Medicina) Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
731149.pdf | 3.69 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License